Pages

Thursday, December 22, 2011

Solos Endoscopy, Inc. Reports Significant Sales From Its MammoView( Instrument Line

BOSTON, Dec. 22, 2011 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company generated $27,455.52 and $30,103.00 in sales for the months of October and November 2011 respectively. Sales for the two month period were primarily driven by the Company's MammoView® Instrument line accounting for 38.9% of the $57,588.52 in sales revenue for October and November. Total mammary ductoscopy sales increased 183% from $7925.00 in October to $14,490.00 in Nove...continued
 

No comments:

Post a Comment